When someone clicks one of your paid ads, the page they land on is the entire transaction — the ad got you the click, but the landing page decides whether that click becomes a consult. You are spending real money to drive affluent local and Latin-American medical-tourism traffic to your service pages, and the bottleneck is no longer traffic. It is what happens in the first eight seconds after the click.
This audit looks at your paid landing experience through two lenses at once. The first is conventional: message match, hero clarity, trust, the call-to-action, objection handling, mobile, and form friction — the levers that move conversion rate. The second is the lens most agencies skip entirely, and the one that carries the largest finding in your whole audit battery: health-claims compliance. Your landing pages are persuasive. That is exactly the problem. The same copy that converts is, in several places, the copy that creates FDA, FTC, and Florida Board of Medicine exposure. A paid landing page is the single most legally visible asset you own, because you are actively paying to put specific health claims in front of strangers, with timestamps, at scale, with a paper trail in your ad account.
The good news embedded in this report: most of what makes your pages risky is also what makes them less trustworthy to a sophisticated cash-pay buyer. Fixing the compliance gate and lifting conversion are, more often than not, the same edit.
For a focused teardown we selected the two pages that, in a clinic with your service mix and ad spend, almost always carry the heaviest paid budget:
| # | Page (illustrative) | Assumed primary paid source | Why it matters |
|---|---|---|---|
| A | /hormone-optimization — flagship "Hormone Optimization & Peptide Therapy" landing | Google Search (high-intent keywords: "hormone therapy Miami", "TRT clinic Miami", "peptide therapy near me") | Highest-ticket, highest-margin service; also the highest-risk claim surface |
| B | /iv-therapy — "IV Vitamin & Recovery Drips" landing | Meta / Instagram (interest + lookalike, image and reel creative) | High volume, social-driven, impulse-leaning; the page most exposed to "structure/function vs disease" claim drift |
Page A is our primary subject because it concentrates the money, the margin, and the compliance risk in one place. Page B appears throughout as the contrast case — a social-traffic page with a different visitor mindset and a different (but equally real) claim problem.
A note on method: we audit the live page as a prospect experiences it, on mobile first, with ad-blocker off and a cold session, and we score against a fixed CRO framework with objection-handling and the compliance gate weighted up for a cash-pay medical context. We did not access analytics, ad-account data, or any patient information; conversion figures below are industry composites for medspa / aesthetic paid traffic, presented as planning benchmarks, not measurements of your account.
Each dimension is scored 0–100. Two dimensions carry extra weight for a cash-pay medical advertiser: Objection handling (because the purchase is high-consideration and trust-gated) and the Health-Claims Compliance gate (because a single non-compliant claim can outweigh every conversion gain on the page). The compliance gate is scored as a gate, not a nice-to-have: a low score here caps how aggressively the rest of the page should be optimized at all.
| # | Dimension | Weight | Page A | Page B | One-line read |
|---|---|---|---|---|---|
| 1 | Message match (ad → page) | 1.0× | 58 | 48 | Headline echoes the ad on A; B's social creative promises a "vibe" the page doesn't pay off |
| 2 | Hero clarity (above the fold) | 1.0× | 60 | 55 | Strong imagery, but the hero leads with the clinic, not the visitor's outcome |
| 3 | Value proposition | 1.0× | 55 | 50 | "Premium" is asserted, not demonstrated; no clear reason-to-choose-you |
| 4 | Trust & credibility signals | 1.2× | 50 | 42 | Physician-led is the asset — and it's buried |
| 5 | Call-to-action (CTA) | 1.0× | 62 | 58 | "Book Now" everywhere; no low-commitment first step |
| 6 | Objection handling | 1.5× | 45 | 40 | Price opacity and "is this safe/legit" go unanswered |
| 7 | Mobile experience | 1.0× | 56 | 52 | Sticky CTA good; form and load weight drag on mobile |
| 8 | Form friction | 1.0× | 48 | 50 | Too many fields, asks for sensitive info too early |
| 9 | Health-Claims Compliance gate | 2.0× | 22 | 28 | Disease-level claims, unqualified testimonials, missing disclosures — the headline finding |
| — | Weighted CRO composite (this teardown) | — | ≈47 | ≈44 | Tracks the audit's overall Sales/conversion (55) and Compliance (25) dimensions |
Weighted CRO composite (this teardown): Page A ≈ 47 · Page B ≈ 44. These track the audit's overall Sales/conversion (55) and Compliance (25) dimensions: your pages convert respectably for a medspa, but the compliance gate is dragging the blended result down and, more importantly, sitting on top of an existential risk that no conversion lift can offset.
Below, each dimension in plain language.
Page A does the fundamentals right: a Google searcher who clicks an ad for "hormone optimization Miami" lands on a page whose H1 is about hormone optimization. Scent is preserved. Where it slips is specificity of promise — the ad copy leans into outcomes ("feel like yourself again," "reclaim your energy") that the page then either over-delivers on (a compliance problem, see the gate) or fails to substantiate (a trust problem).
Page B is the weaker case. Instagram creative sells aesthetics and lifestyle — a glowing model, a drip bar that looks like a lounge — and the landing page drops the visitor into a clinical service description. The emotional register breaks. Social traffic is lower-intent and needs the page to continue the feeling before it asks for a booking.
Both heroes are visually polished — that is genuinely a strength, and consistent with the "modern facility" praise in your reviews. The miss is altitude: the hero talks about the clinic ("Miami's premier longevity destination") instead of the visitor's problem and outcome. Affluent buyers don't doubt that you're premium; they're scanning for "is this for me, specifically." A hero that names the visitor's situation in their words will out-convert a hero that names your brand.
"Premium," "concierge," "cutting-edge" are claims about you, not reasons for them. There's no crisp, defensible answer to "why this clinic over the three other medspas within two miles." The physician-led model is your strongest differentiator and it's treated as a footnote. (We'll return to this — it's also your single best compliance asset.)
You are physician-led. In a category crowded with nurse-only and franchise medspas, that is a meaningful, marketable, and compliance-relevant distinction — and on both pages it's nearly invisible above the fold. There's no named, credentialed supervising physician with a photo and bio on the landing page itself; no medical-license context; no clear "a physician oversees your protocol" statement. Reviews praise your results and concierge service; the page borrows none of that social proof in a structured way.
CTAs are present, contrasting, and repeated — good. The problem is they're all the same heavy ask: "Book Your Appointment." For a several-hundred-to-thousands-of-dollars cash-pay decision, that's a big first step for a cold visitor. There is no lower-commitment on-ramp ("See if you're a candidate," "Get the pricing guide," "Book a free 15-min consult") to capture the large share of visitors who are interested but not ready to book a paid appointment today.
This is your biggest conversion gap, and it maps directly to your reputation data. Reviews show friction around high, opaque pricing perceived as "upsell-y" and inconsistent results messaging. Your landing pages currently answer neither objection. There is no pricing transparency (not even "starting from" or "what's included"), no honest framing of who is and isn't a good candidate, no "what to expect / results vary" section, and no FAQ addressing safety and legitimacy. Every unanswered objection is a visitor who leaves to go read your Google reviews — where they'll find the exact concerns you didn't address. Handling objections on-page is both a conversion win and a reputation firewall.
The sticky bottom CTA is a good instinct. Drags: hero images appear to ship at full desktop weight (slow first paint on a phone over LTE — costly for paid traffic that bounces fast), tap targets in the form crowd together, and the page length forces a lot of scrolling before the first proof point. Most of your medical-tourism and social traffic is on mobile; this is the primary experience, not the fallback.
The consult form asks for too much, too early — typically full name, email, phone, date of birth, and a free-text "describe your concerns" box, sometimes with the service pre-selected and an insurance/health question. Two problems: (a) every extra field measurably lowers completion on a cold paid visitor, and (b) collecting health details and date of birth in a web form raises HIPAA and data-handling questions about how that information is transmitted, stored, and secured. The fix solves both: ask only for name + contact + "best time to reach you," move all clinical questions to the consult itself, and ensure the form posts over a secured, appropriately configured channel.
This is the lowest score in the entire audit and the reason Compliance sits at 25/100 overall. Your pages, as written, make claims that a regulator would read as crossing from permissible structure/function statements into impermissible disease claims — and they do it in paid advertising, which is the most scrutinized surface there is. The four regulators that matter here, and what each is reacting to:
The practical reading: your most persuasive copy is your highest-risk copy. Below are concrete before→after rewrites that keep the persuasion and remove the exposure.
Each rewrite preserves (or improves) conversion intent while moving the claim from disease/drug territory into defensible structure/function language, adds required context, and — where useful — turns the compliance fix into a trust signal. These are illustrative compositions written to demonstrate the pattern; final copy should be reviewed by your own counsel against current FDA/FTC guidance and Florida Board rules.
Before: "Peptide therapy that reverses aging and repairs your body at the cellular level."
After: "Physician-supervised peptide protocols designed to support your body's natural recovery, energy, and wellness goals. Individual results vary; a licensed physician reviews whether peptide therapy is appropriate for you."
Why: "reverses aging" and "repairs your body" are disease/anti-aging cure claims with no substantiation path. The rewrite states a structure/function benefit ("support natural recovery"), names physician oversight (Board of Medicine + trust), and sets a results-vary expectation (FTC).
Before: "Our Immunity Drip boosts your immune system and fights off infection so you never get sick."
After: "Our Immunity Drip delivers hydration plus vitamins and antioxidants that support normal immune function. It is not a treatment for, and does not prevent, any illness or infection."
Why: "fights off infection," "never get sick" are disease-prevention claims. The rewrite keeps the appeal (hydration, vitamins, "support normal immune function" — a recognized structure/function frame) and adds the negative disclaimer that defuses the disease claim.
Before: "Cure your low energy, depression, and brain fog with our hormone therapy."
After: "Many patients pursue hormone optimization to address symptoms like low energy and mental sharpness associated with hormonal changes. Treatment is individualized and provided under physician care; results vary by patient."
Why: naming "depression" turns this into a mental-health disease claim — among the highest-risk possible. "Cure" is a cure claim. The rewrite reframes around symptoms and hormonal change, keeps the emotional pull, and anchors to physician care and variable results.
Before: "I lost 30 lbs and feel 20 years younger — this clinic changed my life!" (photo, no context)
After: "'I lost 30 lbs and feel more energetic.' — Real patient, results shared with permission. Results are not typical and will vary. Your outcome depends on your individual health, plan, and adherence."
Why: unqualified testimonials implying a typical result are a core FTC concern. The rewrite keeps the human proof, adds the "not typical / will vary" qualifier, and signals consent — which also reads as more credible to a savvy buyer.
Before: "We use the most advanced, FDA-approved peptides available."
After: "We use pharmacy-compounded preparations selected by our physician for your protocol. Some compounded preparations are not FDA-approved; your physician will discuss what this means for your care."
Why: describing compounded preparations as "FDA-approved" is likely inaccurate and is itself a deceptive-claim risk. The rewrite is honest, adds the "not FDA-approved" notice where relevant, and frames physician judgment as a feature.
The structure below is built for Page A (hormone optimization) but applies to any high-ticket service page. It is ordered to answer the visitor's questions in the sequence they actually ask them, with the compliance scaffolding built in from the start rather than bolted on.
These are high-leverage, low-effort, and several of them retire real risk immediately:
The pattern worth remembering: on a cash-pay medical landing page, the compliant version is usually the more persuasive version. Honest expectations beat hype with sophisticated buyers, physician accountability is both a trust and a compliance asset, and pricing transparency converts the exact visitors your reviews say you're losing. Fixing the gate and lifting the page are the same project.
Methodology: live mobile-first review of the two highest-spend paid landing pages against a fixed 9-dimension CRO framework (objection handling 1.5×, compliance gate 2.0×); compliance read against FDA structure/function vs disease-claim guidance, FTC substantiation/testimonial/Section 5 standards, Florida Board of Medicine advertising and supervision rules, and HIPAA data-handling expectations. Conversion figures are medspa/aesthetic industry composites for planning, not measurements of the subject's account. Illustrative fictional composite; marketing read, not legal advice.